CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response / STUDIES SUPPORTIVE OF ROLE THAT TECHNOLOGY CAN PLAY IN TREATMENT OF H1N1 HOSPITALIZED PATIENTS

»

09 November 2009 9:16 AM ( 122 days ago)
VIENNA, Va., Nov. 9 /PRNewswire-FirstCall/ CEL-SCI Corporation announced today that Dr. K annith S. Rosenthal, Professor of Immunology and Microbiology of Northeastern Ohio Universities College of Medicine and Pharmacy, reported on work conducted in collaboration with scientists ...
cel sci corporation
To comment or read log in. No account? Register free.




 submit 'CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response / STUDIES SUPPORTIVE OF ROLE THAT TECHNOLOGY CAN PLAY IN TREATMENT OF H1N1 HOSPITALIZED PATIENTS' on facebook   submit 'CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response / STUDIES SUPPORTIVE OF ROLE THAT TECHNOLOGY CAN PLAY IN TREATMENT OF H1N1 HOSPITALIZED PATIENTS' to digg   submit 'CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response / STUDIES SUPPORTIVE OF ROLE THAT TECHNOLOGY CAN PLAY IN TREATMENT OF H1N1 HOSPITALIZED PATIENTS' to Stumbleupon
Comments
No one has commented on this article yet.